Santa Cruz Biotechnology provides a broad selection of PP2A-B55 monoclonal antibodies for various research applications. PP2A-B55 monoclonal antibodies are effective tools for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PP2A-B55 is a regulatory subunit of the protein phosphatase 2A complex, which plays a central role in cellular processes such as cell division, signal transduction, and the regulation of various metabolic pathways. Understanding PP2A-B55 function is essential for advancing cancer biology research and therapeutic development. PP2A-B55 influences multiple cellular pathways and maintains cellular homeostasis through its phosphatase activity. Research has shown that PP2A-B55 dysregulation can contribute to various pathological conditions, making it an important focus in disease studies. Current investigations are exploring PP2A-B55's potential as a therapeutic target in cancer treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of PP2A-B55's role in health and disease.